| Ytd | 2.35% | |
| 1y | -35.00% |
| Open | 0.79 | Prev Close | 0.77 | Low | 0.74 | High | 0.79 | Mkt Cap | 7.96M |
| Vol | 60.09K | Avg Vol | 180.65K | EPS | -0.89 | P/E | N/A | Forward P/E | -4.21 |
| Beta | -0.20 | Short Ratio | 1.09 | Inst. Own | 13.16% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 0.77 | 200-d Avg | 0.82 | 1yr Est | 0.00 |
PMCB News
On December 1, 2025, PharmaCyte Biotech, Inc. (the "Company") received a written notice (th
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announ
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 pe
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recog
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly earnings of $1.54 per share. This is a 566.67 pe
On Monday, 369 companies set new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
Gainers
Gainers
Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Thursday